Bone marrow transplantation alters lung antigen-presenting cells to promote TH17 response and the development of pneumonitis and fibrosis following gammaherpesvirus infection

Mucosal Immunology

Volumn 9, Issue 3, 2016, Pages 610-620

  Zhou, X ^a   Loomis King, H ^a   Gurczynski, S J ^a   Wilke, C A ^a   Konopka, K E ^a   Ptaschinski, C ^a   Coomes, S M ^b   Iwakura, Y ^c   Van Dyk, L F ^d   Lukacs, N W ^a   Moore, B B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; MESSENGER RNA; NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW TRANSPLANTATION; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA VIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; GAMMAHERPESVIRINAE; GAMMAHERPESVIRUS INFECTION; HISTOLOGY; LUNG FIBROSIS; MESENCHYME CELL; MICROSCOPY; MOUSE; NONHUMAN; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH17 CELL; VIRUS LATENCY; VIRUS REPLICATION; ANIMAL; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; FIBROSIS; GENETICS; HERPES VIRUS INFECTION; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; PATHOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; RHADINOVIRUS; VIROLOGY;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIGEN-PRESENTING CELLS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FIBROSIS; HERPESVIRIDAE INFECTIONS; HUMANS; INTERLEUKIN-17; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PNEUMONIA; POSTOPERATIVE COMPLICATIONS; RHADINOVIRUS; TH17 CELLS; VIRUS LATENCY; VIRUS REPLICATION;

EID: 84964963380     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2015.85     Document Type: Article

References (50)

1. Afessa, B. & Peters, S.G. Major complications following hematopoietic stem cell transplantation. Semin. Respir. Crit. Care. Med. 27, 297-309 (2006).
2. Soubani, A.O. & Pandya, C.M. The spectrum of noninfectious pulmonary complications following hematopoietic stem cell transplantation. Hematol. Oncol. Stem. Cell. Ther. 3, 143-157 (2010).
3. Passweg, J.R. et al. Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation. Bone Marrow Transplant. 49, 744-750 (2014).
4. Wingard, J.R., Hsu, J. & Hiemenz, J.W. Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology. Infect. Dis. Clin. North. Am. 24, 257-272 (2010).
5. Yoshihara, S., Yanik, G., Cooke, K.R. & Mineishi, S. Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 13, 749-759 (2007).
6. Uhlving, H.H. et al. Biopsy-verified bronchiolitis obliterans and other noninfectious lung pathologies after allogeneic hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 21, 531-538 (2014).
7. Panoskaltsis-Mortari, A. et al. An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome. Am. J. Respir. Crit. Care. Med. 183, 1262-1279 (2011).
8. Seo, S. et al. Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies. Blood 125, 3789-3797 (2015).
9. Erard, V. et al. Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: The role of community respiratory viruses. J. Infect. Dis. 193, 1619-1625 (2006).
10. Versluys, A.B., Rossen, J.W., van Ewijk, B., Schuurman, R., Bierings, M.B. & Boelens, J.J. Strong association between respiratory viral infection early after hematopoietic stem cell transplantation and the development of life-threatening acute and chronic alloimmune lung syndromes. Biol. Blood Marrow Transplant. 16, 782-791 (2010).
11. Moore, B.B. & Moore, T.A. Viruses in idiopathic pulmonary fibrosis: etiology and exacerbation. Ann. Am. Thorac. Soc., in press (2015).
12. Coomes, S.M., Farmen, S., Wilke, C.A., Laouar, Y. & Moore, B.B. Severe gammaherpesvirus-induced pneumonitis and fibrosis in syngeneic bone marrow transplant mice is related to effects of transforming growth factorbeta. Am. J. Pathol. 179, 2382-2396 (2011).
13. Coomes, S.M., Wilke, C.A., Moore, T.A. & Moore, B.B. Induction of TGF-beta 1, not regulatory T cells, impairs antiviral immunity in the lung following bone marrow transplant. J. Immunol. 184, 5130-5140 (2010).
14. Hubbard, L.L., Ballinger, M.N., Wilke, C.A. & Moore, B.B. Comparison of conditioning regimens for alveolar macrophage reconstitution and innate immune function post bone marrow transplant. Exp. Lung Res. 34, 263-275 (2008).
15. Collins, C.M. & Speck, S.H. Tracking murine gammaherpesvirus 68 infection of germinal center B cells in vivo. PloS One 7, e33230 (2012).
16. Vannella, K.M., Luckhardt, T.R., Wilke, C.A., van Dyk, L.F., Toews, G.B. & Moore, B.B. Latent herpesvirus infection augments experimental pulmonary fibrosis. Am. J. Respir. Crit. Care. Med. 181, 465-477 (2010).
17. Mora, A.L. et al. Control of virus reactivation arrests pulmonary herpesvirus-induced fibrosis in IFN-gamma receptor-deficient mice. Am. J. Respir. Crit. Care. Med. 175, 1139-1150 (2007).
18. van Dyk, L.F., HWt, Virgin & Speck, S.H. Themurine gammaherpesvirus 68 v-cyclin is a critical regulator of reactivation from latency. J. Virol. 74, 7451-7461 (2000).
19. Lea, A.P. & Bryson, H.M. Cidofovir. Drugs 52, 225-230. discussion 231 (1996).
20. Nakae, S. et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17, 375-387 (2002).
21. Lukacs, N.W., Smit, J.J., Mukherjee, S., Morris, S.B., Nunez, G. & Lindell, D.M. Respiratory virus-induced TLR7 activation controls IL-17-associated increased mucus via IL-23 regulation. J. Immunol. 185, 2231-2239 (2010).
22. Yao, Z. et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3, 811-821 (1995).
23. Holt, P.G. & Batty, J.E. Alveolar macrophages. V. Comparative studies on the antigen presentation activity of guinea-pig and rat alveolar macrophages. Immunology 41, 361-366 (1980).
24. Doherty, P.C., Christensen, J.P., Belz, G.T., Stevenson, P.G. & Sangster, M.Y. Dissecting the host response to a gamma-herpesvirus. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356, 581-593 (2001).
25. Travis, E.L., Down, J.D., Holmes, S.J. & Hobson, B. Radiation pneumonitis and fibrosis in mouse lung assayed by respiratory frequency and histology. Radiat. Res. 84, 133-143 (1980).
26. Wilson, M.S. et al. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J. Exp. Med. 207, 535-552 (2010).
27. Mi, S. et al. Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and-independent mechanisms. J. Immuno.l 187, 3003-3014 (2011).
28. Lei, L., Zhong, X.N., He, Z.Y., Zhao, C. & Sun, X.J. IL-21 Induction of CD4+ T cell differentiation into Th17 cells contributes to bleomycininduced fibrosis in mice. Cell Biol Int. 39, 388-399 (2014).
29. Francois, A. et al. B cell activating factor is central to bleomycin-and IL-17-mediated experimental pulmonary fibrosis. J. Autoimmun. 56, 1-11 (2014).
30. Simonian, P.L. et al. Th17-polarized immune response in a murine model of hypersensitivity pneumonitis and lung fibrosis. J. Immunol. 182, 657-665 (2009).
31. Lo, R.e.S. et al. IL-17A-producing gammadelta T and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis. J. Immunol. 184, 6367-6377 (2010).
32. Vanaudenaerde, B.M. et al. The role of the IL23/IL17 axis in bronchiolitis obliterans syndrome after lung transplantation. Am. J. Transplant. 8, 1911-1920 (2008).
33. Mauermann, N. et al. Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17+CD4+ T-cell-mediated graft-versus-host disease. Am. J. Respir. Crit. Care Med. 178, 379-388 (2008).
34. Varelias, A. et al. Lung parenchyma-derived IL-6 promotes IL-17Adependent acute lung injury after allogeneic stem cell transplantation. Blood 125, 2435-2444 (2015).
35. Daley, J.M., Thomay,A.A., Connolly,M.D., Reichner, J.S. & Albina, J.E.Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 83, 64-70 (2008).
36. Neyt, K. & Lambrecht, B.N. The role of lung dendritic cell subsets in immunity to respiratory viruses. Immunol Rev 255, 57-67 (2013).
37. Segura, E. et al. Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity 38, 336-348 (2013).
38. Schlitzer, A. et al. IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 38, 970-983 (2013).
39. Persson, E.K. et al. IRF4 transcription-factor-dependent CD103(+) CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation. Immunity 38, 958-969 (2013).
40. Sheibanie, A.F. et al. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23-4IL-17 axis. J. Immunol. 178, 8138-8147 (2007).
41. Boniface, K. et al. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J. Exp. Med. 206, 535-548 (2009).
42. Sheibanie, A.F., Tadmori, I., Jing, H., Vassiliou, E. & Ganea, D. Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. FASEB J. 18, 1318-1320 (2004).
43. Khayrullina, T., Yen, J.H., Jing, H. & Ganea, D. In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells. J. Immunol. 181, 721-735 (2008).
44. Poloso, N.J., Urquhart, P., Nicolaou, A.,Wang, J. & Woodward, D.F. PGE2 differentially regulates monocyte-derived dendritic cell cytokine responses depending on receptor usage (EP2/EP4). Mol. Immunol. 54, 284-295 (2013).
45. Ballinger, M.N. et al. Critical role of prostaglandin E2 overproduction in impaired pulmonary host response following bone marrow transplantation. J. Immunol. 177, 5499-5508 (2006).
46. Trebino, C.E. et al. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc. Natl Acad Sci. USA 100, 9044-9049 (2003).
47. Boeckh, M. et al. Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: A randomized trial. Ann. Intern. Med. 162, 1-10 (2015).
48. Griffiths, P.D. & Emery, V.C. Taming the transplantation troll by targeting terminase. N. Engl. J. Med. 370, 1844-1846 (2014).
49. Chemaly, R.F. et al. Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation. N. Engl. J. Med. 370, 1781-1789 (2014).
50. Mukherjee, S. et al. IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease. Am. J. Pathol. 179, 248-258 (2011).